Serum interleukin-11 in patients with benign prostatic hyperplasia and prostate cancer

International Urology and Nephrology

Volumn 37, Issue 1, 2005, Pages 69-71

  Furuya, Yuzo ^a,b   Nishio, Remon ^b   Junicho, Akira ^b   Nagakawa, Osamu ^b   Fuse, Hideki ^b  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Interleukin 11; Prostate cancer; Serum levels

Indexed keywords

ANDROGEN; INTERLEUKIN 11; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HORMONE RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

AGED; BIOLOGICAL MARKERS; HUMANS; INTERLEUKIN-11; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 24144456046     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-004-6086-1     Document Type: Article

References (12)

1. Du X Williams DA. 1997 Interleukin-11: Review of molecular, cell biology, and clinical use. Blood 89 3897 9166826
2. G Girasole G Passeri RL Jilka SC. Manolagas 1994 Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest 93 1516 8163655
3. S Akimoto A Okumura H. Fuse 1998 Relationship between serum levels of interleukin-6, tumor necrosis factor-α and bone turnover markers in prostate cancer patients. Endocrine J 45 183
4. J Nakashima M Tachibana Y Horiguchi et al. 2000 Serum interleukin-6 as a prognostic factor in patients with prostate cancer. Clin Cancer Res 6 2702 10914713
5. M Lacroix B Siwek PJ Marie J. Body 1998 Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett 127 29 10.1016/ S0304-3835(97)00542-9 9619855
6. C Sotiriou M Lacroix L Lespagnard et al. 2001 Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases. Cancer Lett 169 87 10.1016/S0304-3835(01)00524-9 11410329
7. CL Campbell Z Jiang DMF Savarese TM. Savarese 2001 Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am J Pathol 158 25 11141475
8. T Yin YC. Yang 1993 Protein tyrosine phosphorylation and activation of primary response genes by interleukin 11 in B9-TY1 cells. Cell Growth Diff 4 603 8398901
9. FJ Hughes GL. Howells 1993 Interleukin-11 inhibits bone formation in vitro. Calcif Tissue Int 53 36210.1007/BF01351844 8287326
10. T. Kishimoto 1989 The biology of interleukin-6. Blood 74 1 2473791
11. B Knoefel K Nuske T Steiner et al. 1997 Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-b1 in primary cultures and modulate T lymphocyte blast transformation. J Interferon Cytokine Res 17 95 9058315
12. T Matsuda A Junicho T Yamamoto et al. 2001 Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells. Biochem Biophys Res Commun. 2001 283 17910.1006/bbrc.2001.4758